Connor, Clark & Lunn Investment Management Ltd. Profound Medical Corp. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding PROF
# of Institutions
52Shares Held
13MCall Options Held
3.3KPut Options Held
9.3K-
Fil LTD Hamilton, D01.82MShares$10.7 Million0.01% of portfolio
-
Gagnon Securities LLC1.75MShares$10.3 Million2.22% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.21MShares$7.09 Million0.15% of portfolio
-
Timelo Investment Management Inc.991KShares$5.82 Million16.97% of portfolio
-
Gagnon Advisors, LLC897KShares$5.26 Million3.86% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $122M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...